Neuropeptide regulation of neurohypophyseal function

神经肽调节神经垂体功能

基本信息

  • 批准号:
    7748924
  • 负责人:
  • 金额:
    $ 27.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-01 至 2012-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Bodily osmolarity is maintained in a narrow physiological range through the release of vasopressin (VP) and oxytocin (OT) into the blood where the hormones act to promote water retention and sodium excretion. The tachykinin, neurokinin B (NKB) and its NK3 receptor (NK3R) have a very unique relationship to VP because NKB and NK3R are co expressed by a majority of magnocellular VP neurons. Magnocellular NK3R are activated in response to physiological challenges because pretreatment with NK3R antagonists block both VP and OT release to both hyperosmolarity and hypovolemia/hypotension. Furthermore, NK3R play a traditional role in cellular signaling and immediate responses to hyperosmolarity and hypovolemia/hypotension and a more sustained role in regulating magnocellular neurons function through direct actions on gene transcription. Following a hyperosmotic challenge NK3R expressed by VP magnocellular neurons were shown to be translocated from the cell membrane to the cell nucleus by confocal microscopy, immuno-electron microscopy and Western blot. Nuclear NK3R was not detected under basal conditions. The translocation of activated g-protein coupled receptors into the nucleus has been hypothesized as a new paradigm for transcriptional regulation. Yet, in spite of the novelty and nuclear signaling importance of NK3R, we know little about NK3R signaling by magnocellular PVN neurons. The goals of this proposal are to identify the role of endogenous NKB and NK3R activation in magnocellular neuron function. Aim 1 will test the hypothesis that NK3R signaling is a "common path" for the activation of magnocellular neurons in the PVN in response to hyperosmotic and hypotensive challenges. Aim 2 will determine the time course of NK3R nuclear translocation and determine if NKB is translocated to the cell nucleus. The experimental hypothesis is that nuclear NK3R affects gene transcription through protein-protein interactions or by binding DNA. Co-immunoprecipitation and chromatin immunoprecipitation will be used to identify the nuclear targets of nuclear NK3R. Aim 3 will examine the effects of sustained hyperosmolarity on the regulation of NK3R and NKB mRNA in the PVN. Aim 4 will identify the source of release of the NK3R ligand (NKB). Results will identify NKB soma that are intrinsic to the PVN or that project to magnocellular PVN neurons and that are activated by hyperosmolarity. Collectively, the results will provide novel insights into membrane-bound receptors acting as nuclear transcription factors and the neurotransmitter systems controlling magnocellular neuron function. Dysfunction of VP release contributes to human pathophysiology, such as congestive heart failure, and the results may suggest novel treatment strategies and/or new insights into genomic underpinnings of human pathologies associated with NK3R system. PUBLIC HEALTH RELEVANCE The proposed research has the potential to contribute to therapies to deal with the dysregulation of neuroendocrine hormones that contribute to pathologies such as congestive heart failure and hypertension. The nuclear translocation of the neurokinin receptor to the nucleus is novel and has implications for a large number of pathologies, such as epilepsy, that are linked to this receptor system in the brain.
描述(由申请方提供):通过将加压素(VP)和催产素(OT)释放到血液中,使身体渗透压维持在狭窄的生理范围内,在血液中激素起促进水潴留和钠排泄的作用。速激肽、神经激肽B(NKB)及其NK 3受体(NK 3 R)与VP有着非常独特的关系,因为NKB和NK 3 R在大多数VP大细胞神经元中共表达。大细胞NK 3R响应于生理挑战而被激活,因为用NK 3R拮抗剂预处理阻断VP和OT释放至高渗透压和低血容量/低血压。此外,NK 3R在细胞信号传导和对高渗透压和低血容量/低血压的即时反应中发挥传统作用,并且通过对基因转录的直接作用在调节大细胞神经元功能中发挥更持续的作用。共聚焦显微镜、免疫电镜和Western blot显示VP大细胞神经元表达的NK 3R在高渗刺激后从细胞膜转位到细胞核。在基础条件下未检测到核NK 3R。活化的g-蛋白偶联受体易位到细胞核中已被假设为转录调控的新范例。然而,尽管NK 3R的新奇和核信号的重要性,我们知道很少NK 3R信号通过大细胞PVN神经元。该建议的目的是确定内源性NKB和NK 3R激活在大细胞神经元功能中的作用。目标1将检验这样的假设:NK 3 R信号传导是PVN中大细胞神经元激活以响应高渗和低血压挑战的“共同路径”。目的2将确定NK 3R核转位的时间过程,并确定NKB是否转位到细胞核。实验假设是核NK 3R通过蛋白质-蛋白质相互作用或通过结合DNA影响基因转录。免疫共沉淀和染色质免疫沉淀将用于鉴定核NK 3R的核靶点。目的3研究持续高渗对室旁核NK 3R和NKB mRNA表达的影响。目的4将确定NK 3R配体(NKB)的释放来源。结果将鉴定出PVN固有的或投射到大细胞PVN神经元并被高渗激活的NKB索马。总的来说,这些结果将为作为核转录因子的膜结合受体和控制大细胞神经元功能的神经递质系统提供新的见解。VP释放功能障碍会导致人类病理生理学,例如充血性心力衰竭,结果可能提出新的治疗策略和/或对与NK 3 R系统相关的人类病理学基因组基础的新见解。 公共卫生相关性拟议的研究有可能有助于治疗神经内分泌激素失调,导致充血性心力衰竭和高血压等病理。神经激肽受体的核转位到细胞核是新颖的,并且对与大脑中的该受体系统相关的大量病理(例如癫痫)具有影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FRANCIS W FLYNN其他文献

FRANCIS W FLYNN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FRANCIS W FLYNN', 18)}}的其他基金

NEUROSCIENCE CORE CENTER
神经科学核心中心
  • 批准号:
    8364909
  • 财政年份:
    2011
  • 资助金额:
    $ 27.31万
  • 项目类别:
NEUROSCIENCE CORE CENTER
神经科学核心中心
  • 批准号:
    8111468
  • 财政年份:
    2011
  • 资助金额:
    $ 27.31万
  • 项目类别:
NEUROSCIENCE CORE CENTER
神经科学核心中心
  • 批准号:
    8686886
  • 财政年份:
    2011
  • 资助金额:
    $ 27.31万
  • 项目类别:
NEUROSCIENCE CORE CENTER
神经科学核心中心
  • 批准号:
    8500399
  • 财政年份:
    2011
  • 资助金额:
    $ 27.31万
  • 项目类别:
NEUROSCIENCE CORE CENTER
神经科学核心中心
  • 批准号:
    8879165
  • 财政年份:
    2011
  • 资助金额:
    $ 27.31万
  • 项目类别:
NEUROSCIENCE CORE CENTER
神经科学核心中心
  • 批准号:
    8235769
  • 财政年份:
    2011
  • 资助金额:
    $ 27.31万
  • 项目类别:
UWY COBRE: ADMINISTRATIVE CORE
UWY COBRE:行政核心
  • 批准号:
    8167714
  • 财政年份:
    2010
  • 资助金额:
    $ 27.31万
  • 项目类别:
UWY COBRE: ADMINISTRATIVE CORE
UWY COBRE:行政核心
  • 批准号:
    7959864
  • 财政年份:
    2009
  • 资助金额:
    $ 27.31万
  • 项目类别:
Neuropeptide regulation of neurohypophyseal function
神经肽调节神经垂体功能
  • 批准号:
    8206570
  • 财政年份:
    2008
  • 资助金额:
    $ 27.31万
  • 项目类别:
Neuropeptide regulation of neurohypophyseal function
神经肽调节神经垂体功能
  • 批准号:
    7458176
  • 财政年份:
    2008
  • 资助金额:
    $ 27.31万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.31万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了